Related Experiment Video
Updated: Jul 10, 2026
11:11
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
[Ad-ING4 inhibits K562 cell growth]
Xin Yu1, Hai-feng Zhang, Jin-zhi Wang
1Cell and Molecular Biology Institute, College of Medicine, Soochow University, Suzhou 215123, China.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|October 18, 2007
Summary
Recombinant adenovirus Ad-ING4 effectively inhibits K562 cell growth and induces apoptosis by modulating bcl-2 and bax expression. This study provides a potential gene therapy approach for tumors.
Area of Science:
- Molecular Biology
- Gene Therapy
- Oncology
Context:
- Investigating the role of ING4 in cellular processes.
- Developing novel adenoviral vectors for therapeutic applications.
- Understanding mechanisms of cancer cell apoptosis.
Purpose:
- To construct a recombinant adenovirus vector expressing human ING4 (Ad-ING4).
- To evaluate the effect of Ad-ING4 on K562 cells, a chronic myeloid leukemia cell line.
- To assess the potential of Ad-ING4 as a therapeutic agent.
Summary:
- A human ING4 recombinant adenovirus vector (Ad-ING4) was successfully constructed.
- Ad-ING4 infection of K562 cells led to significant apoptosis (19.7% at 72h).
- ING4 modulated the expression of apoptosis-related genes, down-regulating bcl-2 and up-regulating bax.
Impact:
- Demonstrates Ad-ING4's efficacy in inhibiting K562 cell proliferation and inducing apoptosis.
- Highlights the potential of ING4-based gene therapy for cancer treatment.
- Provides a foundation for further research into targeted tumor therapy.
Related Concept Videos
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...